Abstract
Aging-related decline in the endocrine and procreative functions of ovaries is the norm, and menopause is the stage of life that is characterized by an eventual cessation of these respective functions. While menopause, as puberty, represents a physiological state, as with puberty, this phase of life may be more challenging for some than others. In this introductory chapter of a textbook on Menopause, our goal is to set the stage, familiarizing the readers with the players (reproductive hormones), the scenes (spectrum of symptoms commonly experienced by women as they approach and enter a new innings of life), and the plot (long-term implications of reproductive senescence).
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Treloar AE. Menstrual cyclicity and the pre-menopause. Maturitas. 1981;3:249–64.
Gold EB, Colvin A, Avis N, Bromberger J, Greendale GA, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women’s health across the nation. Am J Public Health. 2006;96:1226–35.
Thurston RC, Bromberger JT, Joffe H, Avis NE, Hess R, et al. Beyond frequency: who is most bothered by vasomotor symptoms? Menopause. 2008;15:841–7.
Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175:531–9.
Nedstrand E, Wijma K, Lindgren M, Hammar M. The relationship between stress-coping and vasomotor symptoms in postmenopausal women. Maturitas. 1998;31:29–34.
Reynolds F. Relationships between catastrophic thoughts, perceived control and distress during menopausal hot flushes: exploring the correlates of a questionnaire measure. Maturitas. 2000;36:113–22.
Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S, et al. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause. 2005;12:258–66.
Nappi RE, Kokot-Kierepa M. Vaginal health: insights, views & attitudes (VIVA) – results from an international survey. Climacteric. 2012;15:36–44.
Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000;96:351–8.
Simon JA, Nappi RE, Kingsberg SA, Maamari R, Brown V. Clarifying vaginal Atrophy’s impact on sex and relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners. Menopause. 2014;21:137–42.
Kingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (real women’s views of treatment options for menopausal vaginal changes) survey. J Sex Med. 2013;10:1790–9.
Barlow DH, Cardozo LD, Francis RM, Griffin M, Hart DM, et al. Urogenital aging and its effect on sexual health in older Brittish women. Br J Obstet Gynecol. 1997, 104: 87–91.
Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med. 2009;6:2133–42.
Molander U, Milsom I, Ekelund P, Mellstrom D. An epidemiological study of urinary incontinence and related urogenital symptoms in elderly women. Maturitas. 1990;12:51–60.
Brotman RM, Shardell MD, Gajer P, Fadrosh D, Chang K, et al. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause. 2014;21:450–8.
Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. J Sex Med. 2014;11:2865–72.
Bruyniks N, Nappi RE, Castelo-Branco C, de Villiers TJ, Simon J. Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy. Climacteric. 2015;19:1–6.
Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, et al. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause. 2003;10:19–28.
Freeman EW, Sammel MD, Gross SA, Pien GW. Poor sleep in relation to natural menopause: a population-based 14-year follow-up of midlife women. Menopause. 2015;22:719–26.
Ensrud KE, Stone KL, Blackwell TL, Sawaya GF, Tagliaferri M, et al. Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes. Menopause. 2009;16:286–92.
Joffe H, White DP, Crawford SL, McCurnin KE, Economou N, et al. Adverse effects of induced hot flashes on objectively recorded and subjectively reported sleep: results of a gonadotropin-releasing hormone agonist experimental protocol. Menopause. 2013;20:905–14.
Kravitz HM, Zhao X, Bromberger JT, Gold EB, Hall MH, et al. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep. 2008;31:979–90.
Thurston RC, Santoro N, Matthews KA. Are vasomotor symptoms associated with sleep characteristics among symptomatic midlife women? Comparisons of self-report and objective measures. Menopause. 2012;19:742–8.
Freedman RR, Roehrs TA. Lack of sleep disturbance from menopausal hot flashes. Fertil Steril. 2004;82:138–44.
Blumel JE, Cano A, Mezones-Holguin E, Baron G, Bencosme A, et al. A multinational study of sleep disorders during female mid-life. Maturitas. 2012;72:359–66.
Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006–14.
Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165:1286–92.
Bjorvatn B, Leissner L, Ulfberg J, Gyring J, Karlsborg M, et al. Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries. Sleep Med. 2005;6:307–12.
Hogl B, Kiechl S, Willeit J, Saletu M, Frauscher B, et al. Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology. 2005;64:1920–4.
Manconi M, Ulfberg J, Berger K, Ghorayeb I, Wesstrom J, et al. When gender matters: restless legs syndrome. Report of the “RLS and woman” workshop endorsed by the European RLS Study Group. Sleep Med Rev. 2012;16:297–307.
Buysse DJ. Insomnia. JAMA. 2013;309:706–16.
Kessler RC, Berglund P, Demler O, Jin R, Koretz D, et al. The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA. 2003;289:3095–105.
Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? J Psychiatry Neurosci. 2008;33:331–43.
Freeman EW, Sammel MD, Boorman DW, Zhang R. Longitudinal pattern of depressive symptoms around natural menopause. JAMA Psychiatry. 2014;71:36–43.
Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry. 2006;63:385–90.
Bromberger JT, Schott LL, Kravitz HM, Sowers M, Avis NE, et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women’s Health Across the Nation (SWAN). Arch Gen Psychiatry. 2010;67:598–607.
Steinberg EM, Rubinow DR, Bartko JJ, Fortinsky PM, Haq N, et al. A cross-sectional evaluation of perimenopausal depression. J Clin Psychiatry. 2008;69:973–80.
Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, et al. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry. 2004;61:62–70.
Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006;63:375–82.
Georgakis MK, Thomopoulos TP, Diamantaras AA, Kalogirou EI, Skalkidou A, et al. Association of age at menopause and duration of reproductive period with depression after menopause: a systematic review and meta-analysis. JAMA Psychiatry. 2016;73:1–12.
Li L, Wu J, Pu D, Zhao Y, Wan C, et al. Factors associated with the age of natural menopause and menopausal symptoms in Chinese women. Maturitas. 2012;73:354–60.
Chuni N, Sreeramareddy CT. Frequency of symptoms, determinants of severe symptoms, validity of and cut-off score for menopause rating scale (MRS) as a screening tool: a cross-sectional survey among midlife Nepalese women. BMC Womens Health. 2011;11:30.
Blumel JE, Chedraui P, Baron G, Belzares E, Bencosme A, et al. Menopause could be involved in the pathogenesis of muscle and joint aches in mid-aged women. Maturitas. 2013;75:94–100.
El Shafie K, Al Farsi Y, Al Zadjali N, Al Adawi S, Al Busaidi Z, et al. Menopausal symptoms among healthy, middle-aged Omani women as assessed with the menopause rating scale. Menopause. 2011;18:1113–9.
Olaolorun FM, Lawoyin TO. Experience of menopausal symptoms by women in an urban community in Ibadan, Nigeria. Menopause. 2009;16:822–30.
Chlebowski RT, Cirillo DJ, Eaton CB, Stefanick ML, Pettinger M, et al. Estrogen alone and joint symptoms in the Women’s Health Initiative randomized trial. Menopause. 2013;20:600–8.
Harlow SD, Gass M, Hall JE, Lobo R, Maki P, et al. Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19:387–95.
Harlow SD, Gass M, Hall JE, Lobo R, Maki P, et al. Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. Fertil Steril. 2012;97:843–51.
Harlow SD, Gass M, Hall JE, Lobo R, Maki P, et al. Executive summary of the stages of reproductive aging workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric. 2012;15:105–14.
Harlow SD, Gass M, Hall JE, Lobo R, Maki P, et al. Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97:1159–68.
Rossmanith WG, Ruebberdt W. What causes hot flushes? The neuroendocrine origin of vasomotor symptoms in the menopause. Gynecol Endocrinol. 2009;25:303–14.
Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause. 2013;20:888–902; quiz 903–884.
Winneker RC, Harris HA. Progress and prospects in treating postmenopausal vaginal atrophy. Clin Pharmacol Ther. 2011;89:129–32.
Nappi RE, Kokot-Kierepa M. Women’s voices in the menopause: results from an international survey on vaginal atrophy. Maturitas. 2010;67:233–8.
Levine KB, Williams RE, Hartmann KE. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause. 2008;15:661–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Kuokkanen, S., Pal, L. (2017). Reproductive Aging: Epidemiology, Symptomatology, and Nomenclature. In: Pal, L., Sayegh, R. (eds) Essentials of Menopause Management. Springer, Cham. https://doi.org/10.1007/978-3-319-42451-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-42451-4_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42449-1
Online ISBN: 978-3-319-42451-4
eBook Packages: MedicineMedicine (R0)